EDGAR·FLOW

Yarrow Bioscience, Inc. — Form SCHEDULE 13D/A

Filed November 20, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A — Neutral significance 28/100
What the filing says
AI Biotechnology LLC, affiliated with Access Industries, filed an amended Schedule 13D/A on November 20, 2026, disclosing a material ownership position in Yarrow Bioscience, Inc. (a $32M market-cap biotech firm). The filing text provided does not include specific share counts, percentages, acquisition dates, or details of what changed from the original filing—only administrative header information is visible.
Why this rating

Schedule 13D amendments are routine disclosure updates. Without concrete ownership %, share count, or transaction details, cannot assess materiality. Access Industries' involvement suggests institutional backing, but lack of specifics precludes higher scoring.

View original filing on SEC.gov ↗ YARW · stock on Yahoo Finance ↗

See more from November 20, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.